Joshua Yang
CEO
Glyphic Biotechnology is focused on developing a protein-sequencing platform that will provide information on the human proteome at a single molecule resolution.
Current approaches to protein lack the ability to balance efficiency while maintaining high throughput and the ability to detect with a low abundance of proteins.
Glypic Biotechnology is developing a protein-sequencing platform with single-molecule resolution and higher sensitivity.
Our MTM team is working on developing a business strategy and establishing an effective project management workflow by creating pricing models, defining a go-to-market strategy, and managing both internal and external work streams of the company.
CEO
B.S. Molecular, Cellular, and Developmental Biology
University of Colorado, Boulder
B.S. Biochemistry
University of St. Andrews
B.S. Electrical Engineering and Cognitive Neuroscience
Lehigh University